Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Inverness will take over Matritech's businesses for $36mm

Executive Summary

Inverness Medical Innovations (point-of-care testing for women's health, drugs of abuse, cardiovascular conditions, and infectious diseases) will acquire protein-based cancer diagnostics company Matritech for $36mm in stock plus up to $2mm earn-outs based on revenues.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
    • Urine-based Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Payment Includes Stock
    • Intra-Biotech Deal
    • Includes Contract
    • Full Acquisition

Related Companies